Rotablation in Patients with Advanced Renal Insufficiency through End-Stage Renal Disease: Short- and Intermediate-Term Results

Table 5

Independent predicting factors for clinical outcomes in multivariable binary logistic regression analysis.

Variables	In-hospital MACE			6-month MACE
	OR	95% CI	value	OR	95% CI	value
Age	1.12	1.05–1.19	0.001	1.02	1.00–1.05	0.098
Male sex	0.62	0.24–1.63	0.334	1.08	0.64–1.84	0.771
HTN	0.43	0.16–1.14	0.090	0.56	0.33–0.96	0.036
DM	1.11	0.42–2.95	0.836	1.19	0.70–2.02	0.515
PAD	4.42	1.39–14.02	0.012	2.16	1.02–4.57	0.043
Diagnosis of ACS	14.47	2.85–73.42	0.001	4.42	2.02–9.64	<0.001
SVD
DVD			0.996	1.83	0.75–4.43	0.183
TVD + LM			0.996	3.82	1.55–9.45	0.004
Cr ≥5 mg/dl through ESRD	5.44	1.74–17.05	0.004	2.36	1.24–4.50	0.009
Ischemic CM/shock	6.85	1.70–27.68	0.007	4.35	1.87–10.10	0.001
Hemodynamic support	2.54	0.75–8.60	0.134	1.70	0.85–3.40	0.133
SYNTAX score baseline	0.98	0.94–1.03	0.479	0.99	0.96–1.01	0.307
SYNTAX score post	1.07	1.02–1.12	0.010	1.01	0.98–1.04	0.708

Covariates included in the model were age, sex, HTN, DM, PAD, diagnosis of ACS, CAD vessel numbers, creatinine, ischemic cardiomyopathy/cardiogenic shock, hemodynamic support, SYNTAX score baseline, and SYNTAX score post. OR, odds ratio; 95% CI, 95% confidence interval. ACS, acute coronary syndrome; CM, cardiomyopathy; DM, diabetes mellitus; DVD, double-vessel disease; HTN, hypertension; PAD, peripheral artery disease; SVD, single-vessel disease; TVD, triple-vessel disease.